Thomas C. Reynolds, Chief Medical Officer at SEATTLE GENETICS INC /WA (SGEN), sold 125,079 shares at $28.01 ($3.5M) on 2013-01-15, disclosed to the SEC on 2013-01-17.
Scheduled sale ($3.5M) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.00 | 35,492 | $994K | 28.4% |
| 2 | $28.00 | 35,493 | $994K | 28.4% |
| 3 | $28.01 | 3,679 | $103K | 2.9% |
| 4 | $28.01 | 4,167 | $117K | 3.3% |
| 5 | $28.01 | 12,605 | $353K | 10.1% |
| 6 | $28.01 | 33,643 |
| $942K |
| 26.9% |
| Total | $28.00 avg | 125,079 | $3.5M | 100% |
| Filing → |
| SGEN | SELL | 2012-12-10 | $1.7M | — | Filing → |
| SGEN | SELL | 2012-12-06 | $1.0M | — | Filing → |
| SGEN | SELL | 2012-12-03 | $1.0M | — | Filing → |